R. Corey O'Connor
Download the ICS Branding Pack
Open Discussion Session 105 Open Discussion ePosters 544 Surgical Management of Recurrent Stress Urinary Incontinence Following Artificial Urinary Sphincter Placement due to Urethral Atrophy Utilizing the Mature Cuff Pseudocapsule
Open Discussion Session 105 Open Discussion ePosters 592 Fecal Microbiota Transplant in Women Reduces Recurrent Urinary Tract Infection Frequency and Associated Bacterial Resistance
Podium Short Oral Session 10 Updates on the Use of Botulinum Toxin 172 Less Is More – A New Intradetrusor Onabotulinumtoxin A Injection Technique for Neurogenic and Idiopathic Detrusor Overactivity
Non Discussion Poster Session 34 488 COMPARISON OF CLINICAL OUTCOMES BETWEEN “IDEAL” AND “NON-IDEAL” TRANSOBTURATOR MALE SLING PATIENTS FOR TREATMENT OF POST-PROSTATECTOMY STRESS URINARY INCONTINENCE
Non Discussion Poster Session 31 339 Sacral neuromodulation outcomes for idiopathic overactive bladder stratified by indication: lack of anticholinergic efficacy versus intolerability
Non Discussion Poster Session 31 352 Botulinum toxin outcomes for idiopathic overactive bladder stratified by indication: lack of anticholinergic efficacy versus intolerability
Non Discussion Poster Session 31 429 Duloxetine for the treatment of post-prostatectomy stress urinary incontinence
Podium Poster Session 5 Neurourology (Clinical) 39 Voiding dysfunction in patients with dysautonomia
Non Discussion Abstract Session 34 Read by Title 779 Valsalva voiders are at increased risk of urinary retention after mid-urethral sling placement for stress urinary incontinence
Podium Poster Session 12 Clinical Neurourology 103 Unilateral versus Bilateral Stage I Neuromodulator Lead Placement for the Treatment of Refractory Voiding Dysfunction
ICS Member
Dr R. Corey O'Connor declared on the Monday 1st April 2013 that they had the following existing or known future financial relationships or affiliations: